NSHSF(NSHSF)
NSHSF
10/14/26
NanoSphere Health Sciences (NSHSF)
Wednesday
2:37 PM
ThesisRecent clinical trial setbacks and increased competition have raised concerns about the company's ability to maintain its market position and profitability.
Revenue Outlook
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Rev. Growth | — | — |
| EPS | $0.02 | $-0.01 |
| EPS Growth | +210% | -134% |
| P/E | 0.4× | — |
What Moves the Stock
- 01Regulatory approvals for new therapeutic products
- 02Partnerships or collaborations with larger pharmaceutical companies
- 03Clinical trial results impacting product efficacy
- 04Market adoption rates of its nanoparticle delivery technology
- 05Therapeutic products - 100%
- 06Advancements in targeted drug delivery systems
- 07Increased focus on personalized medicine
FY2025 Snapshot
- Revenue
- $0.00
- Gross Margin
- 0.0%
- Op. Margin
- 0.0%
- Net Margin
- 0.0%
- Net Income
- $-86.3K
- NI Growth
- -32859%
- EPS
- $-0.01
- 1Y Return
- +144%
NSHSF Chart
My Notes
- "The market is reacting cautiously as we navigate through competitive pressures and regulatory hurdles."
- Moat: The proprietary nanoparticle technology provides a unique competitive edge, but its durability is challenged by rapid technological…
- growth - Investors seeking high-risk, high-reward opportunities in the biotech sector may find NanoSphere appealing.
- Higher interest rates could increase the cost of capital for NanoSphere, affecting its ability to finance R&D and operational expenses…
- Watch on earnings: Regulatory approval timelines, Clinical trial success rates, Partnership announcements.
One Sentence Summary:
NanoSphere Health Sciences: the story is balanced — regulatory approvals for new therapeutic products.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
